On Monday, Ventyx Biosciences Inc (NASDAQ: VTYX) was 5.51% up from the session before settling in for the closing price of $9.43. A 52-week range for VTYX has been $0.78 – $10.02.
Annual sales at Healthcare sector company slipped by -87.13% over the past five years. When this article was written, the company’s average yearly earnings per share was at 26.52%. With a float of $64.07 million, this company’s outstanding shares have now reached $71.34 million.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ventyx Biosciences Inc stocks. The insider ownership of Ventyx Biosciences Inc is 10.22%, while institutional ownership is 62.14%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.
Ventyx Biosciences Inc (VTYX) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.41 earnings per share (EPS) during the time that was better than consensus figure (set at -0.55) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.89% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
You can see what Ventyx Biosciences Inc (VTYX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 17.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.69 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (NASDAQ: VTYX) saw its 5-day average volume 1.62 million, a negative change from its year-to-date volume of 2.12 million. As of the previous 9 days, the stock’s Stochastic %D was 66.02%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 96.02%, which indicates a significant increase from 84.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.80 in the past 14 days, which was higher than the 0.39 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.77, while its 200-day Moving Average is $2.90. Nevertheless, the first resistance level for the watch stands at $10.38 in the near term. At $10.82, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.35. If the price goes on to break the first support level at $9.41, it is likely to go to the next support level at $8.88. The third support level lies at $8.45 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
There are 71,359K outstanding shares of the company, which has a market capitalization of 710.02 million. As of now, sales total 0 K while income totals -135,120 K. Its latest quarter income was 0 K while its last quarter net income were -22,830 K.
